AdAlta (1AD:ASX) Investor Relations Material

Overview

AdAlta is a groundbreaking biotechnology company that has developed a revolutionary platform for creating unique compounds called i-bodies. These compounds are created by mimicking the shape and stability features of shark antibodies into human proteins, creating a powerful tool for therapeutic intervention in a variety of diseases. AdAlta is at the forefront of this cutting-edge technology and is poised to make a major impact on the world of biotechnology and pharmaceuticals. With their innovative approach and commitment to developing transformative solutions, AdAlta is a company to watch in the years ahead.

Frequently Asked Questions

What is AdAlta's ticker?

AdAlta's ticker is 1AD

What exchange is AdAlta traded on?

The company's shares trade on the ASX stock exchange

Where are AdAlta's headquarters?

They are based in Melbourne, Australia

How many employees does AdAlta have?

There are 1-10 employees working at AdAlta

What is AdAlta's website?

It is https://adalta.com.au/

What type of sector is AdAlta?

AdAlta is in the Healthcare sector

What type of industry is AdAlta?

AdAlta is in the Biotechnology industry

Who are AdAlta's peers and competitors?

The following five companies are AdAlta's industry peers:

- Pfenex Inc

- MorphoSys

- Hepion Pharmaceuticals, Inc.

- ReNeuron

- Erytech Pharma S.A.